About Evolent Health (NYSE:EVH)
Evolent Health, Inc. is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company's platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models. The Company's services include providing its customers, with a population management platform, integrated data and analytics capabilities, pharmacy benefit management (PBM) services and comprehensive health plan administration services. Its value-based operations are empowered and supported by Identifi. Identifi is the Company's technology platform that aggregates and analyzes data, manages care workflows and engages patients.
Industry, Sector and Symbol
Industry COMPUTER SOFT/SERV
SectorComputer and Technology
Trailing P/E Ratio-14.1835287395027
Forward P/E Ratio-41.03
Sales & Book Value
Annual Sales$434.95 million
Price / Sales2.48
Price / CashN/A
Book Value$13.52 per share
Price / Book1.03
Return on Equity-3.51%
Return on Assets-2.79%
Evolent Health (NYSE:EVH) Frequently Asked Questions
What is Evolent Health's stock symbol?
Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."
How were Evolent Health's earnings last quarter?
Evolent Health Inc (NYSE:EVH) released its earnings results on Thursday, November, 2nd. The technology company reported ($0.04) earnings per share for the quarter, topping analysts' consensus estimates of ($0.08) by $0.04. The technology company earned $107.90 million during the quarter, compared to the consensus estimate of $104.49 million. Evolent Health had a negative return on equity of 3.51% and a negative net margin of 14.05%. The firm's quarterly revenue was up 79.2% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.26) earnings per share. View Evolent Health's Earnings History.
Where is Evolent Health's stock going? Where will Evolent Health's stock price be in 2018?
12 analysts have issued 1 year target prices for Evolent Health's stock. Their predictions range from $20.00 to $30.00. On average, they anticipate Evolent Health's stock price to reach $25.33 in the next twelve months. View Analyst Ratings for Evolent Health.
What are Wall Street analysts saying about Evolent Health stock?
Here are some recent quotes from research analysts about Evolent Health stock:
- 1. According to Zacks Investment Research, "Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. " (3/8/2018)
- 2. Cantor Fitzgerald analysts commented, "Health plan acquisitions. Over the past few months, EVH has announced two small health plan acquisitions that should help to grow its platform and operations revenue and add a new line of business. The acquisition of Premier in Dayton, OH, is somewhat more concerning for investors as the regulatory filings show that the plan is in a loss position. However, many provider-owned health plans typically show losses in regulatory filings. The company is expecting to receive better pricing from Premier and that it is not considering additional health plan acquisitions, at least in the near term. However, it will continue to use capital to align the company with customers. Note, our estimates do not yet reflect the health plan acquisitions." (12/3/2017)
Who are some of Evolent Health's key competitors?
Some companies that are related to Evolent Health include Mimecast (MIME), Mantech International (MANT), Alteryx (AYX), BlackLine (BL), Mongodb (MDB), Criteo (CRTO), Q2 (QTWO), MINDBODY (MB), Progress Software (PRGS), Cheetah Mobile (CMCM), Globant (GLOB), TiVo (TIVO), Cyberark Software (CYBR), Shutterstock (SSTK), Bitauto (BITA), Five9 (FIVN), Varonis Systems (VRNS) and Appian (APPN).
Who are Evolent Health's key executives?
Evolent Health's management team includes the folowing people:
- Seth Blackley, President (Age 36)
- Frank John Williams, Chief Executive Officer, Director (Age 50)
- Nicholas P. McGrane, Chief Financial Officer (Age 48)
- Thomas Peterson III, Chief Operating Officer (Age 45)
- Charles W. Pomeroy Jr., Chief Technology Officer (Age 49)
- Lydia Stone, Principal Accounting Officer, Corporate Controller (Age 40)
- Jonathan D. Weinberg, General Counsel (Age 50)
- Dave Thornton, Chief Talent Officer (Age 40)
- Bridget Duffy, Director
- David Farner, Director (Age 53)
When did Evolent Health IPO?
(EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.
Has Evolent Health been receiving favorable news coverage?
Media coverage about EVH stock has been trending somewhat positive on Wednesday, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Evolent Health earned a media sentiment score of 0.08 on Accern's scale. They also gave media headlines about the technology company an impact score of 45.67 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.
Who are Evolent Health's major shareholders?
Evolent Health's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (4.86%), Bank of New York Mellon Corp (4.45%), Millennium Management LLC (3.64%), Riverbridge Partners LLC (3.46%), Eagle Asset Management Inc. (2.62%) and Peregrine Capital Management LLC (2.08%). Company insiders that own Evolent Health stock include Board Co Advisory, Chad Pomeroy, Cheryl Scott, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Michael D'amato, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc, Unitedhealth Group Inc and Upmc. View Institutional Ownership Trends for Evolent Health.
Which major investors are selling Evolent Health stock?
EVH stock was sold by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Thrivent Financial For Lutherans, Sectoral Asset Management Inc, Salem Investment Counselors Inc., UBS Asset Management Americas Inc., Metropolitan Life Insurance Co. NY, TimesSquare Capital Management LLC and Systematic Financial Management LP. Company insiders that have sold Evolent Health company stock in the last year include Board Co Advisory, Cheryl Scott, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Nicholas Mcgrane, Seth Blackley, Steve Wigginton, Thomas Peterson III, Tpg Growth Ii Advisors, Inc, Unitedhealth Group Inc and Upmc. View Insider Buying and Selling for Evolent Health.
Which major investors are buying Evolent Health stock?
EVH stock was purchased by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Standard Life Aberdeen plc, Millennium Management LLC, Carillon Tower Advisers Inc., Riverbridge Partners LLC, Eagle Asset Management Inc., State of Wisconsin Investment Board and Gabelli Funds LLC. View Insider Buying and Selling for Evolent Health.
How do I buy shares of Evolent Health?
Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Evolent Health's stock price today?
One share of EVH stock can currently be purchased for approximately $13.95.
How big of a company is Evolent Health?
Evolent Health has a market capitalization of $1.09 billion and generates $434.95 million in revenue each year. The technology company earns $-60,660,000.00 in net income (profit) each year or ($0.98) on an earnings per share basis. Evolent Health employs 2,600 workers across the globe.
How can I contact Evolent Health?
Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000.
MarketBeat Community Rating for Evolent Health (EVH)MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Evolent Health (NYSE:EVH) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Buy|
|Consensus Rating Score: ||3.00||3.00||3.00||3.07|
|Ratings Breakdown: ||0 Sell Rating(s)|
0 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
0 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
0 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
0 Hold Rating(s)
13 Buy Rating(s)
1 Strong Buy Rating(s)
|Consensus Price Target: ||$25.33||$27.40||$28.00||$29.64|
|Price Target Upside: ||81.60% upside||101.47% upside||117.90% upside||89.37% upside|
Evolent Health (NYSE:EVH) Consensus Price Target History
Evolent Health (NYSE:EVH) Analyst Ratings History
(Data available from 3/21/2016 forward)
Evolent Health (NYSE:EVH) Earnings History and Estimates Chart
Evolent Health (NYSE EVH) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/2/2017||Q3 2017||($0.08)||($0.04)||$104.49 million||$107.90 million||View||N/A|
|8/7/2017||Q2 2017||($0.13)||($0.13)||$104.45 million||$107.30 million||View||Listen|
|5/9/2017||Q1 2017||($0.15)||($0.26)||$104.38 million||$106.80 million||View||Listen|
|2/28/2017||Q416||($0.20)||($0.35)||$84.98 million||$88.00 million||View||Listen|
|11/9/2016||Q316||($0.13)||($0.26)||$58.35 million||$60.20 million||View||Listen|
|8/4/2016||Q216||($0.16)||($0.12)||$51.96 million||$56.50 million||View||N/A|
|5/12/2016||Q116||($0.19)||($0.16)||$47.40 million||$49.50 million||View||Listen|
|2/25/2016||Q415||($0.21)||($0.05)||$43.73 million||$46.70 million||View||Listen|
|11/5/2015||Q315||($0.21)||($0.16)||$42.51 million||$43.30 million||View||N/A|
|8/6/2015||Q215||($0.37)||($1.00)||$157.50 million||$36.50 million||View||N/A|
Evolent Health (NYSE:EVH) Earnings Estimates
2018 EPS Consensus Estimate: ($0.05)
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Evolent Health (NYSE:EVH)
No dividend announcements for this company have been tracked by MarketBeat.com
Evolent Health (NYSE EVH) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 8.79%
Institutional Ownership Percentage: 99.83%
Evolent Health (NYSE EVH) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/1/2018||Unitedhealth Group Inc||Director||Sell||3,040,000||$13.70||$41,648,000.00|| |
|8/3/2017||Frank J. Williams||CEO||Sell||16,300||$23.73||$386,799.00|| |
|8/1/2017||Steve Wigginton||CEO||Sell||6,000||$24.64||$147,840.00|| |
|7/24/2017||Thomas Peterson III||COO||Sell||40,540||$26.00||$1,054,040.00|| |
|7/10/2017||Nicholas Mcgrane||CFO||Sell||1,667||$25.42||$42,375.14|| |
|7/6/2017||Frank J. Williams||CEO||Sell||16,300||$24.76||$403,588.00|| |
|7/3/2017||Steve Wigginton||CEO||Sell||6,000||$25.07||$150,420.00|| |
|6/28/2017||Tpg Growth Ii Advisors, Inc.||Insider||Sell||4,279,325||$25.87||$110,706,137.75|| |
|6/15/2017||Seth Blackley||President||Sell||15,000||$25.22||$378,300.00|| |
|6/12/2017||Nicholas Mcgrane||CFO||Sell||1,667||$24.58||$40,974.86|| |
|6/7/2017||Nicholas Mcgrane||CFO||Sell||10,495||$26.95||$282,840.25|| |
|6/6/2017||Kenneth A. Samet||Director||Sell||4,000||$25.75||$103,000.00|| |
|6/6/2017||Steve Wigginton||CEO||Sell||959||$25.75||$24,694.25|| |
|5/19/2017||Cheryl Scott||Director||Sell||5,477||$23.51||$128,764.27|| |
|5/19/2017||Frank J. Williams||CEO||Sell||114,865||$24.30||$2,791,219.50|| |
|5/19/2017||Jonathan Weinberg||General Counsel||Sell||17,230||$24.30||$418,689.00|| |
|5/19/2017||Nicholas Mcgrane||CFO||Sell||47,508||$24.30||$1,154,444.40|| |
|5/19/2017||Thomas Peterson III||COO||Sell||57,433||$24.30||$1,395,621.90|| |
|5/19/2017||Tpg Growth Ii Advisors, Inc.||Insider||Sell||3,081,760||$24.30||$74,886,768.00|| |
|5/19/2017||Upmc||Major Shareholder||Sell||2,333,333||$24.30||$56,699,991.90||6,434,283|| |
|5/15/2017||Seth Blackley||President||Sell||15,000||$25.00||$375,000.00||760,944|| |
|5/15/2017||Thomas Peterson III||COO||Sell||83,108||$24.99||$2,076,868.92||341,092|| |
|5/10/2017||Nicholas Mcgrane||Insider||Sell||1,667||$24.28||$40,474.76||132,047|| |
|5/10/2017||Thomas Peterson III||COO||Sell||18,604||$25.00||$465,100.00||395,587|| |
|5/4/2017||Frank J Williams||CEO||Sell||16,300||$23.55||$383,865.00||1,284,943|| |
|5/3/2017||Jonathan Weinberg||General Counsel||Sell||15,000||$23.85||$357,750.00||86,385|| |
|5/1/2017||Steve Wigginton||CEO||Sell||6,000||$23.10||$138,600.00||364,704|| |
|5/1/2017||Upmc||Major Shareholder||Sell||403,644||$19.53||$7,883,167.32||8,767,616|| |
|4/19/2017||Nicholas Mcgrane||CFO||Sell||1,667||$22.52||$37,540.84||132,047|| |
|4/17/2017||Seth Blackley||President||Sell||15,000||$21.48||$322,200.00||794,602|| |
|4/6/2017||Frank J Williams||CEO||Sell||16,300||$22.03||$359,089.00||1,301,243|| |
|4/3/2017||Steve Wigginton||CEO||Sell||6,000||$23.15||$138,900.00||364,704|| |
|3/31/2017||Upmc||Major Shareholder||Sell||2,690,961||$19.53||$52,554,468.33||9,171,260|| |
|3/30/2017||Seth Blackley||President||Sell||15,000||$21.19||$317,850.00||807,228|| |
|3/28/2017||Board Co Advisory||Major Shareholder||Sell||2,118,078||$19.53||$41,366,063.34||6,246,245|| |
|3/24/2017||Nicholas Mcgrane||CFO||Sell||7,034||$22.50||$158,265.00||137,414|| |
|1/30/2017||Seth Blackley||President||Sell||15,000||$17.58||$263,700.00||824,848|| |
|1/17/2017||Seth Blackley||President||Sell||30,000||$17.98||$539,400.00||854,848|| |
|11/14/2016||Michael D'amato||Director||Buy||10,000||$17.18||$171,800.00||18,183|| |
|9/22/2016||Board Co Advisory||Major Shareholder||Sell||317,712||$22.50||$7,148,520.00||4,128,167|| |
|9/14/2016||Board Co Advisory||Major Shareholder||Sell||1,936,529||$22.50||$43,571,902.50||4,445,879|| |
|9/14/2016||Chad Pomeroy||Insider||Sell||55,180||$21.54||$1,188,577.20||286,370|| |
|9/14/2016||Frank J Williams||CEO||Sell||251,481||$21.54||$5,416,900.74||1,304,799|| |
|9/14/2016||Jonathan Weinberg||General Counsel||Sell||10,339||$21.54||$222,702.06||76,245|| |
|9/14/2016||Nicholas Mcgrane||CFO||Sell||21,205||$21.54||$456,755.70||136,495|| |
|9/14/2016||Seth Blackley||President||Sell||167,672||$21.54||$3,611,654.88||869,848|| |
|9/14/2016||Thomas Peterson III||COO||Sell||72,827||$21.54||$1,568,693.58||377,623|| |
|6/10/2015||Gary Piefer||Insider||Buy||2,000||$17.00||$34,000.00|| |
Evolent Health (NYSE EVH) News Headlines
|Evolent Health Supports Ten ACOs Accepted to Next Generation ACO Program for 2018 Performance Year|
finance.yahoo.com - March 20 at 4:11 PM
|Evolent Health Inc (EVH) Receives Consensus Rating of "Buy" from Brokerages|
www.americanbankingnews.com - March 18 at 10:20 AM
|Evolent Health (EVH) Downgraded by Zacks Investment Research|
www.americanbankingnews.com - March 8 at 9:58 PM
|Zacks: Brokerages Anticipate Evolent Health Inc (EVH) Will Announce Quarterly Sales of $140.94 Million|
www.americanbankingnews.com - March 8 at 3:48 AM
|Evolent Health Inc (EVH) Director Sells $41,648,000.00 in Stock|
www.americanbankingnews.com - March 5 at 6:22 PM
|Evolent Health Inc (EVH) Stake Decreased by Sectoral Asset Management Inc|
www.americanbankingnews.com - March 5 at 4:06 PM
|State of Wisconsin Investment Board Buys Shares of 400,000 Evolent Health Inc (EVH)|
www.americanbankingnews.com - March 2 at 7:50 PM
|Lombard Odier Asset Management USA Corp Has $4.67 Million Position in Evolent Health Inc (EVH)|
www.americanbankingnews.com - March 2 at 6:16 PM
|Cortina Asset Management LLC Buys 125,053 Shares of Evolent Health Inc (EVH)|
www.americanbankingnews.com - March 2 at 1:32 PM
|Standard Life Aberdeen plc Buys New Holdings in Evolent Health Inc (EVH)|
www.americanbankingnews.com - March 1 at 6:50 PM
|Carillon Tower Advisers Inc. Acquires Shares of 945,560 Evolent Health Inc (EVH)|
www.americanbankingnews.com - March 1 at 5:40 AM
|Canaccord Genuity Lowers Evolent Health (EVH) Price Target to $24.00|
www.americanbankingnews.com - February 28 at 5:52 PM
|Evolent Health (EVH) PT Lowered to $20.00|
www.americanbankingnews.com - February 28 at 4:12 PM
|Evolent Health Announces Fourth Quarter and Full Year 2017 Results - PR Newswire (press release)|
www.prnewswire.com - February 28 at 4:10 PM
|Evolent Health Announces Fourth Quarter and Full Year 2017 Results|
finance.yahoo.com - February 28 at 10:31 AM
|Evolent Health Inc (EVH) Given Average Rating of "Buy" by Brokerages|
www.americanbankingnews.com - February 21 at 12:37 PM
|-$0.04 EPS Expected for Evolent Health Inc (EVH) This Quarter|
www.americanbankingnews.com - February 17 at 11:16 PM
|Jefferies Group Comments on Evolent Health Inc's FY2017 Earnings (EVH)|
www.americanbankingnews.com - February 15 at 7:56 AM
|Jefferies Group Analysts Give Evolent Health (EVH) a $22.00 Price Target|
www.americanbankingnews.com - February 13 at 3:10 PM
|Evolent Health, Inc. to Release Fourth Quarter and Full Year 2017 ... - PR Newswire (press release)|
www.prnewswire.com - February 9 at 3:26 PM
|Evolent Health, Inc. to Release Fourth Quarter and Full Year 2017 Operating Results and Host Conference Call on Tuesday, February 27, 2018|
finance.yahoo.com - February 9 at 3:26 PM
|Evolent Health Inc (EVH) Given Consensus Rating of "Buy" by Analysts|
www.americanbankingnews.com - January 27 at 10:58 AM
|William Blair Comments on Evolent Health Inc's FY2019 Earnings (EVH)|
www.americanbankingnews.com - January 15 at 3:44 PM
|KeyCorp Comments on Evolent Health Inc's Q1 2018 Earnings (EVH)|
www.americanbankingnews.com - January 15 at 5:38 AM
|Evolent Health Inc to Post Q4 2018 Earnings of ($0.01) Per Share, KeyCorp Forecasts (EVH)|
www.americanbankingnews.com - January 12 at 8:02 PM
|Brokers Offer Predictions for Evolent Health Inc's FY2017 Earnings (EVH)|
www.americanbankingnews.com - January 8 at 2:28 AM
|Evolent Health Inc Forecasted to Post Q3 2018 Earnings of ($0.01) Per Share (EVH)|
www.americanbankingnews.com - January 5 at 12:32 PM
|Evolent Health Sees Unusually Large Options Volume (EVH)|
www.americanbankingnews.com - January 5 at 2:10 AM
|Complete Genomics (GNOM) & Evolent Health (EVH) Financial Comparison|
www.americanbankingnews.com - January 4 at 5:04 PM
|Evolent Health Completes Acquisition of Assets from New Mexico ... - PR Newswire (press release)|
www.prnewswire.com - January 2 at 11:27 PM
|Evolent Health Completes Acquisition of Assets from New Mexico Health Connections|
finance.yahoo.com - January 2 at 6:27 PM
|Evolent Health Inc (EVH) Given Average Recommendation of "Buy" by Analysts|
www.americanbankingnews.com - January 2 at 9:58 AM
|Evolent Health Inc (EVH) Short Interest Up 26.5% in December|
www.americanbankingnews.com - January 2 at 4:50 AM
|Evolent Health Inc (EVH) Expected to Post Quarterly Sales of $111.21 Million|
www.americanbankingnews.com - December 31 at 10:28 AM
|Analyzing Cotiviti (COTV) and Evolent Health (EVH)|
www.americanbankingnews.com - December 30 at 3:28 AM
|Evolent Health, Inc. – Value Analysis (NYSE:EVH) : December 29, 2017|
finance.yahoo.com - December 29 at 5:05 PM
|Evolent Health, Inc. breached its 50 day moving average in a Bearish Manner : EVH-US : December 28, 2017|
finance.yahoo.com - December 28 at 8:19 AM
|Evolent Health (EVH) vs. Cotiviti (COTV) Head-To-Head Comparison|
www.americanbankingnews.com - December 27 at 1:20 PM
|Analyzing Evolent Health (EVH) and Press Ganey (PGND)|
www.americanbankingnews.com - December 25 at 3:54 PM
|ETFs with exposure to Evolent Health, Inc. : December 18, 2017|
finance.yahoo.com - December 18 at 5:09 PM
|SunTrust Banks Weighs in on Evolent Health Inc's FY2017 Earnings (EVH)|
www.americanbankingnews.com - December 15 at 7:52 AM
|Evolent Health Inc Forecasted to Post Q1 2018 Earnings of ($0.02) Per Share (EVH)|
www.americanbankingnews.com - December 14 at 11:04 AM
|Evolent Health Inc (EVH) Expected to Post Earnings of -$0.04 Per Share|
www.americanbankingnews.com - December 12 at 1:34 AM
|Premier Health, Virginia company terminate sale of insurance business|
finance.yahoo.com - December 11 at 5:21 PM
|Critical Contrast: Press Ganey (PGND) versus Evolent Health (EVH)|
www.americanbankingnews.com - December 9 at 1:48 AM
|Pre-Open Movers 12/08: (STDY) (SIGM) (ALXN) Higher; (AOBC) (TELL) (LJPC) Lower (more...)|
www.streetinsider.com - December 8 at 5:05 PM
|Evolent Health drops acquisition deal with Ohio company|
finance.yahoo.com - December 8 at 5:05 PM
|Evolent Health Inc (EVH) Given Consensus Recommendation of "Buy" by Analysts|
www.americanbankingnews.com - December 8 at 9:52 AM
|Evolent Health and Premier Health Announce Termination of Agreement for Acquisition of Premier Health Plan|
finance.yahoo.com - December 8 at 9:39 AM
|Analysis of Industry Group Rank Make Evolent Health (EVH) a Sell|
investorplace.com - December 7 at 3:56 PM
Evolent Health (NYSE:EVH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Evolent Health (NYSE:EVH) Income Statement, Balance Sheet and Cash Flow Statement
Evolent Health (NYSE EVH) Stock Chart for Wednesday, March, 21, 2018